Source:http://linkedlifedata.com/resource/pubmed/id/17303764
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2007-3-16
|
pubmed:abstractText |
Apoptosis of cardiomyocytes is increased in heart failure and has been implicated in disease progression. The activation of "proapoptotic" caspases represents a key step in cardiomyocyte apoptosis. In contrast, the role of "proinflammatory" caspases (caspases 1, 4, 5, 11, 12) is unclear. Here, we study the cardiac function of caspase-1. Gene array analysis in a murine heart failure model showed upregulation of myocardial caspase-1. In addition, we found increased expression of caspase-1 protein in murine and human heart failure. Mice with cardiomyocyte-specific overexpression of caspase-1 developed heart failure in the absence of detectable formation of interleukin (IL)-1beta or IL-18 and inflammation. Transgenic caspase-1 induced primary cardiomyocyte apoptosis before structural and molecular signs of myocardial remodeling occurred. In contrast, deletion of endogenous caspase-1 was beneficial in the setting of myocardial infarction-induced heart failure. Furthermore, caspase-1-deficient mice were protected from ischemia/reperfusion-induced cardiomyocyte apoptosis. Studies in primary rat cardiomyocytes indicated that caspase-1 induces cardiomyocyte apoptosis primarily through activation of caspases-3 and -9. In contrast to previous findings, which imply a proinflammatory role of caspase-1, these data suggest a primary proapoptotic role for caspase-1 in cardiomyocytes. Our findings support a functional role for caspase-1-mediated myocardial apoptosis contributing to the progression of heart failure.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1524-4571
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
16
|
pubmed:volume |
100
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
645-53
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:17303764-Animals,
pubmed-meshheading:17303764-Apoptosis,
pubmed-meshheading:17303764-Caspase 1,
pubmed-meshheading:17303764-Caspase 3,
pubmed-meshheading:17303764-Caspase 9,
pubmed-meshheading:17303764-Cells, Cultured,
pubmed-meshheading:17303764-Disease Progression,
pubmed-meshheading:17303764-Female,
pubmed-meshheading:17303764-Heart Failure,
pubmed-meshheading:17303764-Humans,
pubmed-meshheading:17303764-Mice,
pubmed-meshheading:17303764-Mice, Knockout,
pubmed-meshheading:17303764-Mice, Transgenic,
pubmed-meshheading:17303764-Myocytes, Cardiac,
pubmed-meshheading:17303764-Rats,
pubmed-meshheading:17303764-Up-Regulation
|
pubmed:year |
2007
|
pubmed:articleTitle |
A role for caspase-1 in heart failure.
|
pubmed:affiliation |
Rudolf Virchow Center, Deutsche Forschungsgemeinschaft-Research Center for Experimental Biomedicine, Wuerzburg, Germany.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|